Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy

Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 199...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical neurology (Seoul, Korea) Vol. 16; no. 4; pp. 547 - 555
Main Authors Kim, Hyeyun, Kim, Dong Wook, Lee, Soon-Tae, Byun, Jung-Ick, Seo, Jong-Geun, No, Young Joo, Kang, Kyung Wook, Kim, Daeyoung, Kim, Keun Tae, Cho, Yong Won, Yang, Kwang Ik
Format Journal Article
LanguageEnglish
Published Korean Neurological Association 01.10.2020
대한신경과학회
Subjects
Online AccessGet full text
ISSN1738-6586
2005-5013
DOI10.3988/jcn.2020.16.4.547

Cover

Loading…
Abstract Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.
AbstractList Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.
Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures. KCI Citation Count: 0
Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.
Author Lee, Soon-Tae
Seo, Jong-Geun
Kim, Keun Tae
Yang, Kwang Ik
Kim, Hyeyun
Kang, Kyung Wook
Kim, Daeyoung
Byun, Jung-Ick
No, Young Joo
Kim, Dong Wook
Cho, Yong Won
AuthorAffiliation e Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea
g Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea
i Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea
c Department of Neurology, Seoul National University Hospital, Seoul, Korea
f Department of Neurology, Samsung Noble County, Yongin, Korea
h Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
a Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea
b Department of Neurology, Konkuk University School of Medicine, Seoul, Korea
d Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea
j Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea
AuthorAffiliation_xml – name: b Department of Neurology, Konkuk University School of Medicine, Seoul, Korea
– name: e Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea
– name: d Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea
– name: a Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea
– name: i Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea
– name: g Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea
– name: f Department of Neurology, Samsung Noble County, Yongin, Korea
– name: c Department of Neurology, Seoul National University Hospital, Seoul, Korea
– name: h Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
– name: j Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea
Author_xml – sequence: 1
  givenname: Hyeyun
  orcidid: 0000-0002-8008-5539
  surname: Kim
  fullname: Kim, Hyeyun
  organization: Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea
– sequence: 2
  givenname: Dong Wook
  orcidid: 0000-0003-4484-0602
  surname: Kim
  fullname: Kim, Dong Wook
  organization: Department of Neurology, Konkuk University School of Medicine, Seoul, Korea
– sequence: 3
  givenname: Soon-Tae
  orcidid: 0000-0003-4767-7564
  surname: Lee
  fullname: Lee, Soon-Tae
  organization: Department of Neurology, Seoul National University Hospital, Seoul, Korea
– sequence: 4
  givenname: Jung-Ick
  orcidid: 0000-0002-6224-4575
  surname: Byun
  fullname: Byun, Jung-Ick
  organization: Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea
– sequence: 5
  givenname: Jong-Geun
  orcidid: 0000-0002-3944-5731
  surname: Seo
  fullname: Seo, Jong-Geun
  organization: Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea
– sequence: 6
  givenname: Young Joo
  orcidid: 0000-0002-0145-5707
  surname: No
  fullname: No, Young Joo
  organization: Department of Neurology, Samsung Noble County, Yongin, Korea
– sequence: 7
  givenname: Kyung Wook
  orcidid: 0000-0001-9362-8670
  surname: Kang
  fullname: Kang, Kyung Wook
  organization: Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea
– sequence: 8
  givenname: Daeyoung
  orcidid: 0000-0001-9056-0017
  surname: Kim
  fullname: Kim, Daeyoung
  organization: Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 9
  givenname: Keun Tae
  orcidid: 0000-0002-7124-0736
  surname: Kim
  fullname: Kim, Keun Tae
  organization: Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea
– sequence: 10
  givenname: Yong Won
  orcidid: 0000-0002-6127-1045
  surname: Cho
  fullname: Cho, Yong Won
  organization: Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea
– sequence: 11
  givenname: Kwang Ik
  orcidid: 0000-0001-6343-6520
  surname: Yang
  fullname: Yang, Kwang Ik
  organization: Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002632164$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kc1u1DAURi1URKeFB2CXJSyS-t_xBmnUFlqpEgim3VqO40zdZuxgO6Dh6fHMVJXKgtWVfL9zfKXvBBz54C0A7xFsiGzbswfjGwwxbBBvaMOoeAUWGEJWM4jIEVggQdqas5Yfg5OUHiDkArboDTgmBGIpmVyAu6XPzk5utFN2prqI87r6YUdrsgu-WhoTYu_8usqhPLs_c7TVajvZypVlP4-5-qYL73Oqfrt8X13uTWn7Frwe9Jjsu6d5Cm4_X67Or-qbr1-uz5c3taEI5hp3tuew7wYthDC47RgiPemZ1Ax1QvaCYQkNQgOnVMNOaAtZp-XAO9pKhgw5BR8PXh8H9WicCtrt5zqox6iW31fXSrIWc45L9tMhO83dxvamXB31qKboNjpu9-TLjXf3xfNLCUaRFKQIPjwJYvg525TVxiVjx1F7G-akMKUSM9oyWqLoEDUxpBTt8PwNgmrXnSrdqV13CnFFVemuMOIfxrisdz2Ua9z4H_IvwoSg6Q
CitedBy_id crossref_primary_10_1016_j_snb_2024_136766
crossref_primary_10_1186_s12967_023_04490_z
crossref_primary_10_3390_jcm13133983
crossref_primary_10_1177_20420986231181337
crossref_primary_10_1016_j_cardfail_2021_07_020
crossref_primary_10_3390_healthcare12080830
crossref_primary_10_1002_adma_202203667
crossref_primary_10_1016_j_yebeh_2022_108611
crossref_primary_10_20961_plexus_v2i3_566
crossref_primary_10_1016_j_bbe_2022_04_004
crossref_primary_10_1021_acs_analchem_3c05641
crossref_primary_10_1016_j_seizure_2021_03_009
crossref_primary_10_1007_s40263_023_01013_8
crossref_primary_10_1016_j_eplepsyres_2023_107138
crossref_primary_10_2174_0118715273275793231030060833
crossref_primary_10_3390_pharmaceutics15020306
crossref_primary_10_17749_2077_8333_epi_par_con_2024_210
crossref_primary_10_1166_jbt_2022_2968
crossref_primary_10_17340_jkna_2023_1_17
crossref_primary_10_1016_j_survophthal_2025_01_002
crossref_primary_10_1007_s11064_024_04244_3
crossref_primary_10_3390_biomedicines11071955
Cites_doi 10.2165/00003088-200645110-00002
10.1212/WNL.43.11.2292
10.1016/j.jpainsymman.2018.07.012
10.1212/WNL.0b013e3182194bd3
10.1016/j.eplepsyres.2017.10.003
10.1136/archdischild-2012-302822
10.1111/j.1528-1157.1987.tb05766.x
10.2147/NDT.S188111
10.1056/NEJMoa0902014
10.1056/NEJM199712183372504
10.1016/j.seizure.2010.10.027
10.1016/j.eplepsyres.2007.06.002
10.1016/j.seizure.2008.06.009
10.1111/j.0013-9580.2004.06204.x
10.1111/j.1468-1331.2004.00874.x
10.1007/s40265-015-0514-7
10.1136/bmj.286.6373.1246
10.1212/01.wnl.0000297512.18364.40
10.1111/epi.13671
10.3310/hta11370
10.1016/j.yebeh.2016.11.018
10.1007/s40272-019-00325-x
10.1016/j.seizure.2003.06.001
10.1038/jhg.2017.91
10.1016/S0140-6736(07)60461-9
10.1111/j.1499-1654.2000.001597.x
10.1016/j.yebeh.2016.04.002
10.2147/NDT.S185774
10.1016/S1059-1311(95)80003-4
10.1016/S0140-6736(07)60460-7
10.1016/S0887-8994(02)00468-X
10.1016/j.braindev.2016.02.005
10.1016/j.nurt.2006.10.005
10.1016/j.seizure.2018.10.016
10.1007/s40263-016-0344-5
10.1016/j.yebeh.2020.106942
10.1111/epi.13502
10.1016/j.seizure.2013.07.006
10.1016/j.seizure.2007.04.007
10.1111/j.1528-1167.2006.00585.x
10.1053/seiz.2000.0444
10.1212/WNL.55.2.236
10.1046/j.1528-1157.2001.31600.x
10.1016/j.nurt.2006.11.004
10.1212/WNL.0000000000001930
10.1684/epd.2008.0168
10.1111/j.1469-8749.2008.03099.x
ContentType Journal Article
Copyright Copyright © 2020 Korean Neurological Association.
Copyright © 2020 Korean Neurological Association 2020 Korean Neurological Association
Copyright_xml – notice: Copyright © 2020 Korean Neurological Association.
– notice: Copyright © 2020 Korean Neurological Association 2020 Korean Neurological Association
CorporateAuthor on behalf of the Drug Committee of Korean Epilepsy Society
CorporateAuthor_xml – name: on behalf of the Drug Committee of Korean Epilepsy Society
DBID AAYXX
CITATION
7X8
5PM
ACYCR
DOI 10.3988/jcn.2020.16.4.547
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-5013
EndPage 555
ExternalDocumentID oai_kci_go_kr_ARTI_9582662
PMC7541973
10_3988_jcn_2020_16_4_547
GroupedDBID 29K
2WC
5-W
5GY
8JR
8XY
9ZL
AAKDD
AAYXX
ACYCR
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
D-I
DIK
DU5
E3Z
EF.
F5P
GROUPED_DOAJ
HYE
KQ8
M48
OK1
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c410t-2bed60dbfa777c28b513d3d59a51b79d75290c11f644a0b7ae05ba9f6b48951c3
IEDL.DBID M48
ISSN 1738-6586
IngestDate Sun Mar 09 07:50:40 EDT 2025
Thu Aug 21 14:15:02 EDT 2025
Fri Jul 11 00:54:31 EDT 2025
Thu Apr 24 22:50:31 EDT 2025
Tue Jul 01 03:10:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c410t-2bed60dbfa777c28b513d3d59a51b79d75290c11f644a0b7ae05ba9f6b48951c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
https://doi.org/10.3988/jcn.2020.16.4.547
ORCID 0000-0003-4484-0602
0000-0002-8008-5539
0000-0003-4767-7564
0000-0002-6127-1045
0000-0002-6224-4575
0000-0001-9056-0017
0000-0002-3944-5731
0000-0001-6343-6520
0000-0002-7124-0736
0000-0001-9362-8670
0000-0002-0145-5707
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3988/jcn.2020.16.4.547
PMID 33029959
PQID 2449254854
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9582662
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7541973
proquest_miscellaneous_2449254854
crossref_primary_10_3988_jcn_2020_16_4_547
crossref_citationtrail_10_3988_jcn_2020_16_4_547
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-01
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-01
  day: 01
PublicationDecade 2020
PublicationTitle Journal of clinical neurology (Seoul, Korea)
PublicationYear 2020
Publisher Korean Neurological Association
대한신경과학회
Publisher_xml – name: Korean Neurological Association
– name: 대한신경과학회
References Davies (10.3988/jcn.2020.16.4.547_ref10) 1995; 4
Machado (10.3988/jcn.2020.16.4.547_ref47) 2013; 22
Zhu (10.3988/jcn.2020.16.4.547_ref11) 2017; 62
Vossler (10.3988/jcn.2020.16.4.547_ref48) 2008; 10
French (10.3988/jcn.2020.16.4.547_ref5) 2004; 45
Glauser (10.3988/jcn.2020.16.4.547_ref40) 2010; 362
Brigo (10.3988/jcn.2020.16.4.547_ref41) 2017; 2
French (10.3988/jcn.2020.16.4.547_ref34) 2011; 76
Motte (10.3988/jcn.2020.16.4.547_ref49) 1997; 337
Sun (10.3988/jcn.2020.16.4.547_ref27) 2009; 18
Allen (10.3988/jcn.2020.16.4.547_ref37) 1983; 286
Brodie (10.3988/jcn.2020.16.4.547_ref1) 2010; 19
Chadwick (10.3988/jcn.2020.16.4.547_ref20) 1987; 28 Suppl 2
Marson (10.3988/jcn.2020.16.4.547_ref18) 2007; 11
Verrotti (10.3988/jcn.2020.16.4.547_ref44) 2008; 50
Appleton (10.3988/jcn.2020.16.4.547_ref6) 2012; 97
Krakow (10.3988/jcn.2020.16.4.547_ref29) 2007; 16
Johannessen (10.3988/jcn.2020.16.4.547_ref13) 2006; 45
Vossler (10.3988/jcn.2020.16.4.547_ref30) 2016; 57
Shih (10.3988/jcn.2020.16.4.547_ref31) 2017; 69
Barcs (10.3988/jcn.2020.16.4.547_ref26) 2000; 41
Maiti (10.3988/jcn.2020.16.4.547_ref15) 2017; 138
Fisher (10.3988/jcn.2020.16.4.547_ref14) 2017; 58
Chen (10.3988/jcn.2020.16.4.547_ref21) 2019; 15
Marson (10.3988/jcn.2020.16.4.547_ref16) 2007; 369
Byun (10.3988/jcn.2020.16.4.547_ref17) 2020; 105
Korean Epilepsy Society (10.3988/jcn.2020.16.4.547_ref9) 2015
National Clinical Guideline Centre (10.3988/jcn.2020.16.4.547_ref36) 2012
Fabris (10.3988/jcn.2020.16.4.547_ref4) 2016; 60
Scott (10.3988/jcn.2020.16.4.547_ref2) 2015; 75
Jozwiak (10.3988/jcn.2020.16.4.547_ref24) 2000; 9
The US Gabapentin Study Group No. 5 (10.3988/jcn.2020.16.4.547_ref23) 1993; 43
Dahlin (10.3988/jcn.2020.16.4.547_ref43) 2003; 28
Almeida (10.3988/jcn.2020.16.4.547_ref33) 2007; 4
Glauser (10.3988/jcn.2020.16.4.547_ref8) 2006; 47
Bektaş (10.3988/jcn.2020.16.4.547_ref52) 2016; 38
Scottish Intercollegiate Guidelines Network (10.3988/jcn.2020.16.4.547_ref7) 2011
French (10.3988/jcn.2020.16.4.547_ref39) 2015; 85
Kessler (10.3988/jcn.2020.16.4.547_ref45) 2019; 21
Jedrzejczak (10.3988/jcn.2020.16.4.547_ref28) 2005; 12
Hoy (10.3988/jcn.2020.16.4.547_ref3) 2016; 30
Cereghino (10.3988/jcn.2020.16.4.547_ref19) 2000; 55
von Rosenstiel (10.3988/jcn.2020.16.4.547_ref32) 2007; 4
Kumar (10.3988/jcn.2020.16.4.547_ref38) 2004; 13
Verrotti (10.3988/jcn.2020.16.4.547_ref50) 2018; 63
Marson (10.3988/jcn.2020.16.4.547_ref35) 2007; 369
Howard (10.3988/jcn.2020.16.4.547_ref12) 2018; 56
Montenegro (10.3988/jcn.2020.16.4.547_ref22) 2001; 42
Steinhoff (10.3988/jcn.2020.16.4.547_ref25) 2007; 76
Balagura (10.3988/jcn.2020.16.4.547_ref51) 2020; 16
Noachtar (10.3988/jcn.2020.16.4.547_ref46) 2008; 70
Nevitt (10.3988/jcn.2020.16.4.547_ref42) 2018; 8
References_xml – volume: 45
  start-page: 1061
  year: 2006
  ident: 10.3988/jcn.2020.16.4.547_ref13
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-200645110-00002
– volume: 43
  start-page: 2292
  year: 1993
  ident: 10.3988/jcn.2020.16.4.547_ref23
  publication-title: Neurology
  doi: 10.1212/WNL.43.11.2292
– volume: 56
  start-page: 645
  year: 2018
  ident: 10.3988/jcn.2020.16.4.547_ref12
  publication-title: J Pain Symptom Manage
  doi: 10.1016/j.jpainsymman.2018.07.012
– volume: 76
  start-page: 1555
  year: 2011
  ident: 10.3988/jcn.2020.16.4.547_ref34
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182194bd3
– volume: 138
  start-page: 5
  year: 2017
  ident: 10.3988/jcn.2020.16.4.547_ref15
  publication-title: Epilepsy Res
  doi: 10.1016/j.eplepsyres.2017.10.003
– volume: 97
  start-page: 1073
  year: 2012
  ident: 10.3988/jcn.2020.16.4.547_ref6
  publication-title: Arch Dis Child
  doi: 10.1136/archdischild-2012-302822
– volume: 28 Suppl 2
  start-page: S12
  year: 1987
  ident: 10.3988/jcn.2020.16.4.547_ref20
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.1987.tb05766.x
– volume: 15
  start-page: 905
  year: 2019
  ident: 10.3988/jcn.2020.16.4.547_ref21
  publication-title: Neuropsychiatr Dis Treat
  doi: 10.2147/NDT.S188111
– volume: 362
  start-page: 790
  year: 2010
  ident: 10.3988/jcn.2020.16.4.547_ref40
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0902014
– volume: 337
  start-page: 1807
  year: 1997
  ident: 10.3988/jcn.2020.16.4.547_ref49
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199712183372504
– volume: 19
  start-page: 650
  year: 2010
  ident: 10.3988/jcn.2020.16.4.547_ref1
  publication-title: Seizure
  doi: 10.1016/j.seizure.2010.10.027
– volume: 76
  start-page: 6
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref25
  publication-title: Epilepsy Res
  doi: 10.1016/j.eplepsyres.2007.06.002
– volume: 18
  start-page: 90
  year: 2009
  ident: 10.3988/jcn.2020.16.4.547_ref27
  publication-title: Seizure
  doi: 10.1016/j.seizure.2008.06.009
– volume: 45
  start-page: 401
  year: 2004
  ident: 10.3988/jcn.2020.16.4.547_ref5
  publication-title: Epilepsia
  doi: 10.1111/j.0013-9580.2004.06204.x
– volume: 12
  start-page: 176
  year: 2005
  ident: 10.3988/jcn.2020.16.4.547_ref28
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2004.00874.x
– volume: 75
  start-page: 2143
  year: 2015
  ident: 10.3988/jcn.2020.16.4.547_ref2
  publication-title: Drugs
  doi: 10.1007/s40265-015-0514-7
– volume: 286
  start-page: 1246
  year: 1983
  ident: 10.3988/jcn.2020.16.4.547_ref37
  publication-title: Br Med J (Clin Res Ed)
  doi: 10.1136/bmj.286.6373.1246
– volume: 70
  start-page: 607
  year: 2008
  ident: 10.3988/jcn.2020.16.4.547_ref46
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000297512.18364.40
– volume: 58
  start-page: 531
  year: 2017
  ident: 10.3988/jcn.2020.16.4.547_ref14
  publication-title: Epilepsia
  doi: 10.1111/epi.13671
– volume: 11
  issue: 37
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref18
  publication-title: Health Technol Assess
  doi: 10.3310/hta11370
– volume: 69
  start-page: 186
  year: 2017
  ident: 10.3988/jcn.2020.16.4.547_ref31
  publication-title: Epilepsy Behav
  doi: 10.1016/j.yebeh.2016.11.018
– volume: 21
  start-page: 15
  year: 2019
  ident: 10.3988/jcn.2020.16.4.547_ref45
  publication-title: Paediatr Drugs
  doi: 10.1007/s40272-019-00325-x
– volume: 13
  start-page: 475
  year: 2004
  ident: 10.3988/jcn.2020.16.4.547_ref38
  publication-title: Seizure
  doi: 10.1016/j.seizure.2003.06.001
– volume: 62
  start-page: 1009
  year: 2017
  ident: 10.3988/jcn.2020.16.4.547_ref11
  publication-title: J Hum Genet
  doi: 10.1038/jhg.2017.91
– volume: 369
  start-page: 1016
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref35
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60461-9
– volume: 41
  start-page: 1597
  year: 2000
  ident: 10.3988/jcn.2020.16.4.547_ref26
  publication-title: Epilepsia
  doi: 10.1111/j.1499-1654.2000.001597.x
– volume-title: Clinical guideline for antiepileptic drug treatment in patient with epilepsy
  year: 2015
  ident: 10.3988/jcn.2020.16.4.547_ref9
– volume: 60
  start-page: 17
  year: 2016
  ident: 10.3988/jcn.2020.16.4.547_ref4
  publication-title: Epilepsy Behav
  doi: 10.1016/j.yebeh.2016.04.002
– volume: 16
  start-page: 369
  year: 2020
  ident: 10.3988/jcn.2020.16.4.547_ref51
  publication-title: Neuropsychiatr Dis Treat
  doi: 10.2147/NDT.S185774
– volume: 4
  start-page: 267
  year: 1995
  ident: 10.3988/jcn.2020.16.4.547_ref10
  publication-title: Seizure
  doi: 10.1016/S1059-1311(95)80003-4
– volume: 369
  start-page: 1000
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref16
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60460-7
– volume: 28
  start-page: 48
  year: 2003
  ident: 10.3988/jcn.2020.16.4.547_ref43
  publication-title: Pediatr Neurol
  doi: 10.1016/S0887-8994(02)00468-X
– volume: 38
  start-page: 654
  year: 2016
  ident: 10.3988/jcn.2020.16.4.547_ref52
  publication-title: Brain Dev
  doi: 10.1016/j.braindev.2016.02.005
– volume: 2
  start-page: CD003032
  year: 2017
  ident: 10.3988/jcn.2020.16.4.547_ref41
  publication-title: Cochrane Database Syst Rev
– volume: 4
  start-page: 88
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref33
  publication-title: Neurotherapeutics
  doi: 10.1016/j.nurt.2006.10.005
– volume: 63
  start-page: 17
  year: 2018
  ident: 10.3988/jcn.2020.16.4.547_ref50
  publication-title: Seizure
  doi: 10.1016/j.seizure.2018.10.016
– volume: 30
  start-page: 559
  year: 2016
  ident: 10.3988/jcn.2020.16.4.547_ref3
  publication-title: CNS Drugs
  doi: 10.1007/s40263-016-0344-5
– volume: 105
  start-page: 106942
  year: 2020
  ident: 10.3988/jcn.2020.16.4.547_ref17
  publication-title: Epilepsy Behav
  doi: 10.1016/j.yebeh.2020.106942
– volume: 57
  start-page: 1625
  year: 2016
  ident: 10.3988/jcn.2020.16.4.547_ref30
  publication-title: Epilepsia
  doi: 10.1111/epi.13502
– volume: 8
  start-page: CD001769
  year: 2018
  ident: 10.3988/jcn.2020.16.4.547_ref42
  publication-title: Cochrane Database Syst Rev
– volume: 22
  start-page: 846
  year: 2013
  ident: 10.3988/jcn.2020.16.4.547_ref47
  publication-title: Seizure
  doi: 10.1016/j.seizure.2013.07.006
– volume: 16
  start-page: 593
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref29
  publication-title: Seizure
  doi: 10.1016/j.seizure.2007.04.007
– volume: 47
  start-page: 1094
  year: 2006
  ident: 10.3988/jcn.2020.16.4.547_ref8
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2006.00585.x
– volume: 9
  start-page: 486
  year: 2000
  ident: 10.3988/jcn.2020.16.4.547_ref24
  publication-title: Seizure
  doi: 10.1053/seiz.2000.0444
– volume-title: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
  year: 2012
  ident: 10.3988/jcn.2020.16.4.547_ref36
– volume: 55
  start-page: 236
  year: 2000
  ident: 10.3988/jcn.2020.16.4.547_ref19
  publication-title: Neurology
  doi: 10.1212/WNL.55.2.236
– volume: 42
  start-page: 539
  year: 2001
  ident: 10.3988/jcn.2020.16.4.547_ref22
  publication-title: Epilepsia
  doi: 10.1046/j.1528-1157.2001.31600.x
– volume: 4
  start-page: 84
  year: 2007
  ident: 10.3988/jcn.2020.16.4.547_ref32
  publication-title: Neurotherapeutics
  doi: 10.1016/j.nurt.2006.11.004
– volume-title: SIGN 50: a guideline developer's handbook
  year: 2011
  ident: 10.3988/jcn.2020.16.4.547_ref7
– volume: 85
  start-page: 950
  year: 2015
  ident: 10.3988/jcn.2020.16.4.547_ref39
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001930
– volume: 10
  start-page: 31
  year: 2008
  ident: 10.3988/jcn.2020.16.4.547_ref48
  publication-title: Epileptic Disord
  doi: 10.1684/epd.2008.0168
– volume: 50
  start-page: 850
  year: 2008
  ident: 10.3988/jcn.2020.16.4.547_ref44
  publication-title: Dev Med Child Neurol
  doi: 10.1111/j.1469-8749.2008.03099.x
SSID ssj0067081
Score 2.3111496
SecondaryResourceType review_article
Snippet Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin,...
Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin,...
SourceID nrf
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 547
SubjectTerms Review
신경과학
Title Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy
URI https://www.proquest.com/docview/2449254854
https://pubmed.ncbi.nlm.nih.gov/PMC7541973
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002632164
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Clinical Neurology, 2020, 16(4), , pp.547-555
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9wwEBY5oPSlNGlLNxdq6FPBi2zrsB5CCTlIA1sK7Za8CUmWEyfBm3q9kPTXd8b2LjWE0ieDD1nMaDzf5xHzEfJRZwGLbQEWL5YZbeKjLOcq0tw6Dfkj-JYoTr7Kiym_vBJXa2Qpb9UbcP4stUM9qWl9P3789fQZAv4IGacGAnfrsZFpAuEvx3wsuFonm5CYJC7yCV8VFaRirWZprCDGIfHKrsj5_BCDNLVe1cUAgQ73T_6VkM5fk1c9kqTHneu3yFqotsmLSV8rf0N-HldNGR4g6uGr4Olpvbim31vVG3AFRZWIGvMWbWZwuvy9qANFUkpLuIhNOei3ruXqnOK_WnrWjjR_ekum52c_Ti6iXkUh8jxmTZS4kEuWu8IqpXySORGneZoLbUXslM6VSDTzcVwAMrLMKRuYcFYX0vEM4JdP35GNalaF94SywgOdchmAqgKIVWYdV5llSZ7K1PtUjQhbGs34vsU4Kl3cG6AaaGcDdjZoZxNLww3YeUQ-rR556Ppr_OvmQ_CEufOlwa7YeLyembvaAPb_YmBCgDaSEfmwdJSBUMH6h63CbDE3gGQ08OFM8BFRAw-uXo3DDq9U5U3bdFsJHmuV7vzPFHbJS5x3t-dvj2w09SLsA3Zp3EHL-Q_adfkHK8vs3Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiepileptic+Drug+Selection+According+to+Seizure+Type+in+Adult+Patients+with+Epilepsy&rft.jtitle=Journal+of+clinical+neurology+%28Seoul%2C+Korea%29&rft.au=%EA%B9%80%ED%98%9C%EC%9C%A4&rft.au=%EA%B9%80%EB%8F%99%EC%9A%B1&rft.au=%EC%9D%B4%EC%88%9C%ED%83%9C&rft.au=%EB%B3%80%EC%A0%95%EC%9D%B5&rft.date=2020-10-01&rft.pub=%EB%8C%80%ED%95%9C%EC%8B%A0%EA%B2%BD%EA%B3%BC%ED%95%99%ED%9A%8C&rft.issn=1738-6586&rft.eissn=2005-5013&rft.spage=547&rft.epage=555&rft_id=info:doi/10.3988%2Fjcn.2020.16.4.547&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9582662
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6586&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6586&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6586&client=summon